Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study

This study sought to assess the malignant risks of "unspecified" thyroid nodules; that is, nodules that were not of a type described in the 2015 American Thyroid Association (ATA) guidelines.We retrospectively reviewed medical records and ultrasound (US) data for 1808 consecutive patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2018-12, Vol.97 (52), p.e13914-e13914
Hauptverfasser: Gao, Luying, Xi, Xuehua, Wang, Juanjuan, Yang, Xiao, Wang, Ying, Zhu, Shenling, Lai, Xingjian, Zhang, Xiaoyan, Zhao, Ruina, Zhang, Bo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e13914
container_issue 52
container_start_page e13914
container_title Medicine (Baltimore)
container_volume 97
creator Gao, Luying
Xi, Xuehua
Wang, Juanjuan
Yang, Xiao
Wang, Ying
Zhu, Shenling
Lai, Xingjian
Zhang, Xiaoyan
Zhao, Ruina
Zhang, Bo
description This study sought to assess the malignant risks of "unspecified" thyroid nodules; that is, nodules that were not of a type described in the 2015 American Thyroid Association (ATA) guidelines.We retrospectively reviewed medical records and ultrasound (US) data for 1808 consecutive patients with 2614 thyroid nodules who underwent thyroidectomy between January 2015 and December 2015. Nodules with US features that did not satisfy the criteria for any risk category in the 2015 ATA guidelines were defined as "unspecified" nodules. These thyroid nodules were retrospectively assessed using the Thyroid Imaging, Reporting and Data System proposed by Kwak (Kwak-TIRADS) and the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR-TIRADS).There were 70 "unspecified" nodules (2.7%, 70/2614), and 18.6% (13/70) of these nodules were malignant. The percentages of nodules with Kwak-TIRADS grades 4a, 4b and 4c were 53.3%, 40.0%, and 6.7%, respectively. The percentages of nodules with ACR-TIRADS grades TR2, TR3, TR4, and TR5 were 5.7%, 2.9%, 70.0%, and 21.4%, respectively. Among the "unspecified" nodules, there were significantly more nodules in Kwak-TIRADS categories 4b and 4c in the malignant pathology group than in the benign pathology group (P 
doi_str_mv 10.1097/MD.0000000000013914
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6314728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2161702062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3557-a28eeea7d320c331acfcd785acd116fe92f6c4cad844e81a091a5428d43fbac53</originalsourceid><addsrcrecordid>eNpdkctuEzEUhkcIRNPCEyAhL9lM8XU8wwIp6gWQWrFp15Zrn0lMPXawPamy64MAD9cnYUJCuXhzZJ___3yO_qp6RfAxwZ18e3l6jP8cwjrCn1QzIlhTi67hT6sZxlTUspP8oDrM-ctWJCl_Xh0wLDpGCZlVP659STrHMViUXL5FsNZ-1MXFgGKPynKTorMoRDt6yNNdF6QToIf7b2PIKzCud2Af7r8jF6YuIIqJQPMBkjM6oKu9f55zNG6HHXTQCxggFLQYnQXvAuR3aI4SlBS3zOLWgHIZ7eZF9azXPsPLfT2qrs_Prk4-1hefP3w6mV_Uhgkha01bANDSMooNY0Sb3ljZCm0sIU0PHe0bw422LefQEo07ogWnreWsv9FGsKPq_Y67Gm8GsGYaLmmvVskNOm1U1E792wluqRZxrRpGuKTtBHizB6T4dYRc1OCyAe91gDhmRUlDJKa4oZOU7aRm2jYn6B-_IVhtk1WXp-r_ZCfX678nfPT8jnIS8J3gLvoCKd_68Q6SWoL2ZfmLJ2RH6ymfllDa4np6aSX7CXRytQY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161702062</pqid></control><display><type>article</type><title>Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Gao, Luying ; Xi, Xuehua ; Wang, Juanjuan ; Yang, Xiao ; Wang, Ying ; Zhu, Shenling ; Lai, Xingjian ; Zhang, Xiaoyan ; Zhao, Ruina ; Zhang, Bo</creator><creatorcontrib>Gao, Luying ; Xi, Xuehua ; Wang, Juanjuan ; Yang, Xiao ; Wang, Ying ; Zhu, Shenling ; Lai, Xingjian ; Zhang, Xiaoyan ; Zhao, Ruina ; Zhang, Bo</creatorcontrib><description>This study sought to assess the malignant risks of "unspecified" thyroid nodules; that is, nodules that were not of a type described in the 2015 American Thyroid Association (ATA) guidelines.We retrospectively reviewed medical records and ultrasound (US) data for 1808 consecutive patients with 2614 thyroid nodules who underwent thyroidectomy between January 2015 and December 2015. Nodules with US features that did not satisfy the criteria for any risk category in the 2015 ATA guidelines were defined as "unspecified" nodules. These thyroid nodules were retrospectively assessed using the Thyroid Imaging, Reporting and Data System proposed by Kwak (Kwak-TIRADS) and the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR-TIRADS).There were 70 "unspecified" nodules (2.7%, 70/2614), and 18.6% (13/70) of these nodules were malignant. The percentages of nodules with Kwak-TIRADS grades 4a, 4b and 4c were 53.3%, 40.0%, and 6.7%, respectively. The percentages of nodules with ACR-TIRADS grades TR2, TR3, TR4, and TR5 were 5.7%, 2.9%, 70.0%, and 21.4%, respectively. Among the "unspecified" nodules, there were significantly more nodules in Kwak-TIRADS categories 4b and 4c in the malignant pathology group than in the benign pathology group (P &lt;.01).Our results imply that "unspecified" thyroid nodules based on the ATA guidelines could partly be evaluated using the Kwak-TIRADS and that the ATA guidelines could incorporate more accurate malignant risk stratification.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000013914</identifier><identifier>PMID: 30593211</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Adult ; Aged ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Observational Study ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Assessment ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - diagnostic imaging ; Thyroid Neoplasms - pathology ; Thyroid Nodule - diagnosis ; Thyroid Nodule - diagnostic imaging ; Thyroid Nodule - pathology ; Thyroid Nodule - surgery ; Thyroidectomy - statistics &amp; numerical data ; Ultrasonography ; United States</subject><ispartof>Medicine (Baltimore), 2018-12, Vol.97 (52), p.e13914-e13914</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3557-a28eeea7d320c331acfcd785acd116fe92f6c4cad844e81a091a5428d43fbac53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314728/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314728/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30593211$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Luying</creatorcontrib><creatorcontrib>Xi, Xuehua</creatorcontrib><creatorcontrib>Wang, Juanjuan</creatorcontrib><creatorcontrib>Yang, Xiao</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Zhu, Shenling</creatorcontrib><creatorcontrib>Lai, Xingjian</creatorcontrib><creatorcontrib>Zhang, Xiaoyan</creatorcontrib><creatorcontrib>Zhao, Ruina</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><title>Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>This study sought to assess the malignant risks of "unspecified" thyroid nodules; that is, nodules that were not of a type described in the 2015 American Thyroid Association (ATA) guidelines.We retrospectively reviewed medical records and ultrasound (US) data for 1808 consecutive patients with 2614 thyroid nodules who underwent thyroidectomy between January 2015 and December 2015. Nodules with US features that did not satisfy the criteria for any risk category in the 2015 ATA guidelines were defined as "unspecified" nodules. These thyroid nodules were retrospectively assessed using the Thyroid Imaging, Reporting and Data System proposed by Kwak (Kwak-TIRADS) and the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR-TIRADS).There were 70 "unspecified" nodules (2.7%, 70/2614), and 18.6% (13/70) of these nodules were malignant. The percentages of nodules with Kwak-TIRADS grades 4a, 4b and 4c were 53.3%, 40.0%, and 6.7%, respectively. The percentages of nodules with ACR-TIRADS grades TR2, TR3, TR4, and TR5 were 5.7%, 2.9%, 70.0%, and 21.4%, respectively. Among the "unspecified" nodules, there were significantly more nodules in Kwak-TIRADS categories 4b and 4c in the malignant pathology group than in the benign pathology group (P &lt;.01).Our results imply that "unspecified" thyroid nodules based on the ATA guidelines could partly be evaluated using the Kwak-TIRADS and that the ATA guidelines could incorporate more accurate malignant risk stratification.</description><subject>Adult</subject><subject>Aged</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Practice Guidelines as Topic</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - diagnostic imaging</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Thyroid Nodule - diagnosis</subject><subject>Thyroid Nodule - diagnostic imaging</subject><subject>Thyroid Nodule - pathology</subject><subject>Thyroid Nodule - surgery</subject><subject>Thyroidectomy - statistics &amp; numerical data</subject><subject>Ultrasonography</subject><subject>United States</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctuEzEUhkcIRNPCEyAhL9lM8XU8wwIp6gWQWrFp15Zrn0lMPXawPamy64MAD9cnYUJCuXhzZJ___3yO_qp6RfAxwZ18e3l6jP8cwjrCn1QzIlhTi67hT6sZxlTUspP8oDrM-ctWJCl_Xh0wLDpGCZlVP659STrHMViUXL5FsNZ-1MXFgGKPynKTorMoRDt6yNNdF6QToIf7b2PIKzCud2Af7r8jF6YuIIqJQPMBkjM6oKu9f55zNG6HHXTQCxggFLQYnQXvAuR3aI4SlBS3zOLWgHIZ7eZF9azXPsPLfT2qrs_Prk4-1hefP3w6mV_Uhgkha01bANDSMooNY0Sb3ljZCm0sIU0PHe0bw422LefQEo07ogWnreWsv9FGsKPq_Y67Gm8GsGYaLmmvVskNOm1U1E792wluqRZxrRpGuKTtBHizB6T4dYRc1OCyAe91gDhmRUlDJKa4oZOU7aRm2jYn6B-_IVhtk1WXp-r_ZCfX678nfPT8jnIS8J3gLvoCKd_68Q6SWoL2ZfmLJ2RH6ymfllDa4np6aSX7CXRytQY</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Gao, Luying</creator><creator>Xi, Xuehua</creator><creator>Wang, Juanjuan</creator><creator>Yang, Xiao</creator><creator>Wang, Ying</creator><creator>Zhu, Shenling</creator><creator>Lai, Xingjian</creator><creator>Zhang, Xiaoyan</creator><creator>Zhao, Ruina</creator><creator>Zhang, Bo</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181201</creationdate><title>Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study</title><author>Gao, Luying ; Xi, Xuehua ; Wang, Juanjuan ; Yang, Xiao ; Wang, Ying ; Zhu, Shenling ; Lai, Xingjian ; Zhang, Xiaoyan ; Zhao, Ruina ; Zhang, Bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3557-a28eeea7d320c331acfcd785acd116fe92f6c4cad844e81a091a5428d43fbac53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Practice Guidelines as Topic</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - diagnostic imaging</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Thyroid Nodule - diagnosis</topic><topic>Thyroid Nodule - diagnostic imaging</topic><topic>Thyroid Nodule - pathology</topic><topic>Thyroid Nodule - surgery</topic><topic>Thyroidectomy - statistics &amp; numerical data</topic><topic>Ultrasonography</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Luying</creatorcontrib><creatorcontrib>Xi, Xuehua</creatorcontrib><creatorcontrib>Wang, Juanjuan</creatorcontrib><creatorcontrib>Yang, Xiao</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Zhu, Shenling</creatorcontrib><creatorcontrib>Lai, Xingjian</creatorcontrib><creatorcontrib>Zhang, Xiaoyan</creatorcontrib><creatorcontrib>Zhao, Ruina</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Luying</au><au>Xi, Xuehua</au><au>Wang, Juanjuan</au><au>Yang, Xiao</au><au>Wang, Ying</au><au>Zhu, Shenling</au><au>Lai, Xingjian</au><au>Zhang, Xiaoyan</au><au>Zhao, Ruina</au><au>Zhang, Bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>97</volume><issue>52</issue><spage>e13914</spage><epage>e13914</epage><pages>e13914-e13914</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>This study sought to assess the malignant risks of "unspecified" thyroid nodules; that is, nodules that were not of a type described in the 2015 American Thyroid Association (ATA) guidelines.We retrospectively reviewed medical records and ultrasound (US) data for 1808 consecutive patients with 2614 thyroid nodules who underwent thyroidectomy between January 2015 and December 2015. Nodules with US features that did not satisfy the criteria for any risk category in the 2015 ATA guidelines were defined as "unspecified" nodules. These thyroid nodules were retrospectively assessed using the Thyroid Imaging, Reporting and Data System proposed by Kwak (Kwak-TIRADS) and the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR-TIRADS).There were 70 "unspecified" nodules (2.7%, 70/2614), and 18.6% (13/70) of these nodules were malignant. The percentages of nodules with Kwak-TIRADS grades 4a, 4b and 4c were 53.3%, 40.0%, and 6.7%, respectively. The percentages of nodules with ACR-TIRADS grades TR2, TR3, TR4, and TR5 were 5.7%, 2.9%, 70.0%, and 21.4%, respectively. Among the "unspecified" nodules, there were significantly more nodules in Kwak-TIRADS categories 4b and 4c in the malignant pathology group than in the benign pathology group (P &lt;.01).Our results imply that "unspecified" thyroid nodules based on the ATA guidelines could partly be evaluated using the Kwak-TIRADS and that the ATA guidelines could incorporate more accurate malignant risk stratification.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>30593211</pmid><doi>10.1097/MD.0000000000013914</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2018-12, Vol.97 (52), p.e13914-e13914
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6314728
source MEDLINE; DOAJ Directory of Open Access Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Aged
Diagnosis, Differential
Female
Humans
Male
Middle Aged
Observational Study
Practice Guidelines as Topic
Retrospective Studies
Risk Assessment
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - diagnostic imaging
Thyroid Neoplasms - pathology
Thyroid Nodule - diagnosis
Thyroid Nodule - diagnostic imaging
Thyroid Nodule - pathology
Thyroid Nodule - surgery
Thyroidectomy - statistics & numerical data
Ultrasonography
United States
title Ultrasound risk evaluation of thyroid nodules that are “unspecified” in the 2015 American Thyroid Association management guidelines: A retrospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A11%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultrasound%20risk%20evaluation%20of%20thyroid%20nodules%20that%20are%20%E2%80%9Cunspecified%E2%80%9D%20in%20the%202015%20American%20Thyroid%20Association%20management%20guidelines:%20A%20retrospective%20study&rft.jtitle=Medicine%20(Baltimore)&rft.au=Gao,%20Luying&rft.date=2018-12-01&rft.volume=97&rft.issue=52&rft.spage=e13914&rft.epage=e13914&rft.pages=e13914-e13914&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000013914&rft_dat=%3Cproquest_pubme%3E2161702062%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161702062&rft_id=info:pmid/30593211&rfr_iscdi=true